Accendra Health, Inc.
NYSE:ACHMedical - Distribution
+$0.12 today
- Market cap
- $54.22M
- Beta
- 1.63
- P/E (TTM)
- -0.2
- EPS (TTM)
- -$14.11
Volume 1.41M
Average 0.83M
ACH Total Non-current Assets
All assets not expected to be converted to cash within one year.
Accendra Health, Inc.NYSE: ACH
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets falls 31.0% from a year ago
Total non-current assets stood at $1.83B at the end of Q1 FY2026, down 31.0% from a year earlier and down 4.0% from the prior quarter. Over 3 fiscal years it compounded at -14.9% a year.
Context
- Total non-current assets amounted to 75.6% of total assets at the end of Q1 FY2026, up 21.1 pp from a year earlier.
- Total non-current assets increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current assets keeps falling in the next quarterly balance sheet after a -31.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 1.9B USD
- Year-over-year change
- -27.7%
- 4-year CAGR
- +11.9%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.9B | -27.7% |
| FY2024 | 2024-12-31 | 2.63B | -12.0% |
| FY2023 | 2023-12-31 | 2.99B | -3.3% |
| FY2022 | 2022-12-31 | 3.09B | +154.5% |
| FY2021 | 2021-12-31 | 1.21B | — |
Total Non-current Assets vs competitors
How ACH compares with its peers on the latest reported figures
- Peers report in different currencies, so total non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -31.0% is the 8th highest of 11, against a peer median of -13.4%.
- Total non-current assets amounts to 75.6% of total assets for ACH, versus a peer median of 15.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.83B USD | -31.0% | -14.9% | 75.6% | |
| Mar 2026 | CA$589.27M CAD | -5.4% | -15.5% | 52.7% | |
| Apr 2026 | CA$216.44M CAD | +37.0% | +0.2% | 62.2% | |
| Mar 2026 | $122.67M USD | -43.3% | -18.6% | 31.0% | |
| Mar 2026 | $88.49M USD | -0.9% | -26.6% | 44.5% | |
| Mar 2026 | $25.83M USD | -15.4% | +47.7% | 17.4% | |
| Mar 2026 | $21.27M USD | -45.2% | -47.6% | 14.2% | |
| Mar 2026 | $12.75M USD | -13.0% | -19.9% | 5.1% | |
BIOABioAge Labs, Inc. | Mar 2026 | $5.79M USD | -69.6% | +172.8% | 1.5% |
| Mar 2026 | $3.19M USD | +15.0% | -8.9% | 2.9% | |
| Mar 2026 | $2.98M USD | -13.8% | +15.2% | 3.0% | |
| Peer median (excluding ACH) | — | -13.4% | -12.2% | 15.8% | |
Competitors are the stored peer set for ACH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 55.71M | 69.47M | 243.04M | 49.38M | 281.99M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 681.56M | 763.5M | 598.26M | 690.24M | 95.91M |
| Inventory | 1.5B | 1.33B | 1.11B | 1.13B | 74.44M |
| Other Current Assets | 88.56M | 128.64M | 150.89M | 149.52M | 95.54M |
| Total Current Assets | 2.32B | 2.3B | 2.1B | 2.02B | 547.87M |
| Property, Plant & Equipment (Net) | 511.24M | 858.93M | 840.51M | 864.97M | 365.26M |
| Goodwill | 390.19M | 1.64B | 1.64B | 1.33B | 1.23B |
| Intangible Assets | 243.75M | 483.74M | 361.84M | 296.73M | 136.47M |
| Long-term Investments | 16.32M | 15.46M | 8.45M | 6.11M | 1.34M |
| Tax Assets | 0 | 0 | (8.45M) | 0 | 0 |
| Other Non-current Assets | 53.25M | 96.26M | 149.35M | 134.05M | 172.69M |
| Total Non-current Assets | 1.21B | 3.09B | 2.99B | 2.63B | 1.9B |
| Total Assets | 3.54B | 5.39B | 5.09B | 4.66B | 2.45B |
| Account Payables | 1B | 1.15B | 1.17B | 1.25B | 363.57M |
| Short-term Debt | 43.85M | 15.38M | 204.08M | 40M | 293.27M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 116.4M | 0 | 0 |
| Other Current Liabilities | 182.35M | 227.44M | 191.66M | 425.54M | 220.81M |
| Total Current Liabilities | 1.34B | 1.57B | 1.89B | 1.87B | 947.08M |
| Long-term Debt | 936.23M | 2.47B | 1.88B | 1.8B | 1.87B |
| Deferred Tax Liabilities | 35.31M | 60.83M | 41.65M | 22.46M | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 108.94M | 114.94M | 122.59M | 100.13M | 25.15M |
| Total Non-current Liabilities | 1.25B | 2.87B | 2.28B | 2.22B | 1.97B |
| Total Liabilities | 2.6B | 4.44B | 4.17B | 4.09B | 2.91B |
| Common Stock | 150.87M | 152.56M | 153.09M | 154.4M | 152.78M |
| Retained Earnings | 387.62M | 410.01M | 368.71M | 6.02M | (1.08B) |
| Accumulated OCI | (40.59M) | (35.85M) | (31.82M) | (49.34M) | (885K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 938.5M | 945.6M | 924.17M | 565.23M | (460.98M) |
| Total Debt | 1.15B | 2.79B | 2.41B | 2.14B | 2.23B |
| Net Debt | 1.1B | 2.72B | 2.16B | 2.09B | 1.95B |
Accendra Health, Inc.
NYSE:ACH
Intrinsic Alpha fair value
Locked
Current Price
$0.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.